156 related articles for article (PubMed ID: 22116800)
1. Oxidative DNA damage and somatic mutations: a link to the molecular pathogenesis of chronic inflammatory airway diseases.
Tzortzaki EG; Dimakou K; Neofytou E; Tsikritsaki K; Samara K; Avgousti M; Amargianitakis V; Gousiou A; Menikou S; Siafakas NM
Chest; 2012 May; 141(5):1243-1250. PubMed ID: 22116800
[TBL] [Abstract][Full Text] [Related]
2. Somatic DNA alterations in lung epithelial barrier cells in COPD patients.
Samara KD; Tzortzaki EG; Neofytou E; Karatzanis AD; Lambiri I; Tzanakis N; Siafakas NM
Pulm Pharmacol Ther; 2010 Jun; 23(3):208-14. PubMed ID: 20040382
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of 8-OHdG formation and hOGG1 induction in PBMCs for assessing oxidative DNA damage in the lung of COPD patients.
Yang S; Wu H; Zhao J; Wu X; Zhao J; Ning Q; Xu Y; Xie J
Respirology; 2014 Nov; 19(8):1183-90. PubMed ID: 25154311
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite DNA instability in nasal cytology of COPD patients.
Karatzanis AD; Samara KD; Tzortzaki E; Zervou M; Helidonis ES; Velegrakis GA; Siafakas N
Oncol Rep; 2007 Mar; 17(3):661-5. PubMed ID: 17273748
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite DNA instability and COPD exacerbations.
Makris D; Tzanakis N; Damianaki A; Ntaoukakis E; Neofytou E; Zervou M; Siafakas NM; Tzortzaki EG
Eur Respir J; 2008 Sep; 32(3):612-8. PubMed ID: 18508815
[TBL] [Abstract][Full Text] [Related]
6. Differences in microsatellite DNA level between asthma and chronic obstructive pulmonary disease.
Zervou MI; Tzortzaki EG; Makris D; Gaga M; Zervas E; Economidou E; Tsoumakidou M; Tzanakis N; Milic-Emili J; Siafakas NM
Eur Respir J; 2006 Sep; 28(3):472-8. PubMed ID: 16707512
[TBL] [Abstract][Full Text] [Related]
7. Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer.
Caramori G; Adcock IM; Casolari P; Ito K; Jazrawi E; Tsaprouni L; Villetti G; Civelli M; Carnini C; Chung KF; Barnes PJ; Papi A
Thorax; 2011 Jun; 66(6):521-7. PubMed ID: 21460372
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite DNA instability in COPD.
Siafakas NM; Tzortzaki EG; Sourvinos G; Bouros D; Tzanakis N; Kafatos A; Spandidos D
Chest; 1999 Jul; 116(1):47-51. PubMed ID: 10424502
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and airway inflammation in severe exacerbations of COPD.
Drost EM; Skwarski KM; Sauleda J; Soler N; Roca J; Agusti A; MacNee W
Thorax; 2005 Apr; 60(4):293-300. PubMed ID: 15790984
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
[TBL] [Abstract][Full Text] [Related]
12. Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass.
Ceylan E; Kocyigit A; Gencer M; Aksoy N; Selek S
Respir Med; 2006 Jul; 100(7):1270-6. PubMed ID: 16307872
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress in COPD patients, smokers, and non-smokers.
Tavilani H; Nadi E; Karimi J; Goodarzi MT
Respir Care; 2012 Dec; 57(12):2090-4. PubMed ID: 22710284
[TBL] [Abstract][Full Text] [Related]
15. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD.
Kinnula VL; Ilumets H; Myllärniemi M; Sovijärvi A; Rytilä P
Eur Respir J; 2007 Jan; 29(1):51-5. PubMed ID: 17050565
[TBL] [Abstract][Full Text] [Related]
16. [Concentration of nitric oxide exhaled air (eNO) in patients with COPD and bronchiectasis].
Ziora D; Kałuska K; Rauer R; Kozielski J
Pneumonol Alergol Pol; 2003; 71(9-10):418-27. PubMed ID: 15052978
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease.
Van Pottelberge GR; Mestdagh P; Bracke KR; Thas O; van Durme YM; Joos GF; Vandesompele J; Brusselle GG
Am J Respir Crit Care Med; 2011 Apr; 183(7):898-906. PubMed ID: 21037022
[TBL] [Abstract][Full Text] [Related]
18. [Development of chronic obstructive pulmonary disease correlates with mini- and microsatellite locus instability].
Chizhikov VV; Chikina SIu; Tatosian AG; Chuchalin AG; Zborovskaia IB
Genetika; 2003 May; 39(5):694-701. PubMed ID: 12838617
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between increased mitochondrial DNA
Karimova A; Oltulu YM; Azaklı H; Kara M; Ustek D; Tutluoglu B; Onaran I
Mitochondrial DNA A DNA Mapp Seq Anal; 2017 May; 28(3):361-369. PubMed ID: 26713688
[TBL] [Abstract][Full Text] [Related]
20. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.
Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I
Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
